Status:
NOT_YET_RECRUITING
Effect of Graminex on Infertility Related to Male Accessory Glands Inflammation
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Male Infertility
Prostatitis
Eligibility:
MALE
20-55 years
Phase:
NA
Brief Summary
Male Accessory Glands Inflammations (MAGI) include inflammatory diseases involving seminal vescicles and the prostate. Patients suffering from them present an impaired fertility because of seminal duc...
Eligibility Criteria
Inclusion
- Male patients with a diagnosis of MAGI based on clinical and/or ultrasonographic criteria.
Exclusion
- History of cryptorchidism, orchitis, testicular torsion or trauma,
- Hypogonadism,
- Occupational chemical exposure,
- Y chromosome microdeletions, karyotype abnormalities and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutations,
- ultrasound testicular volume \<12 mL,
- FSH \>8 mUI/L,
- fever or drug use within 3 months prior to the enrollment in this study
- azoospermia.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06974175
Start Date
September 1 2025
End Date
May 1 2026
Last Update
August 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Italy, 00168